2015 Clinical Investigator Award Recipient

George_MillerGeorge Miller, MD
New York University School of Medicine
Modulation of tumor-promoting influences of y&T cells in pancreatic carcinoma in a Phase II clinical trial utilizing perioperative gemcitabine + nab-paclitaxel
Supported by an educational grant from Genentech

George Miller is a hepatobiliary surgical oncologist at NYU School of Medicine and one of the leading academic surgeons in the world. He is Vice Chair of NYU’s Surgery Department, Director of NYU’s Cancer Immunology Program, and is PI on the only T32 training program in GI Oncology in the country. His research interests include understanding immune regulation of pancreatic and liver oncogenesis. Dr. Miller leads one of the most dynamic tumor immunology labs in the country. In 2016 alone he was the senior author on papers in Nature, Cell, and Nature Medicine. He is the PI on 3 active R01 grants and has been awarded 12 federal grants, and more than 40 awards total, over the past 6 years. Dr. Miller’s areas of investigation include novel target identification, development of new biologics, and translation to clinical trial. Dr. Miller is also an accomplished HPB surgeon and has been nominated for University-wide teaching awards.